NEW YORK CITY, NY / ACCESS Newswire / August 31, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of KinderCare Learning Companies, Inc. (NYSE:KLC) pursuant and/or traceable to the registration statement issued in connection with KinderCare’s October 2024 initial public offering, of the important October 14, […]

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the “Class Period”), of the important October 10, 2025 lead plaintiff deadline. So what: If you purchased SelectQuotesecurities during the Class Period you may be

NEW YORK, NY / ACCESS Newswire / August 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeMD, Inc. ("LifeMD, Inc.") (NASDAQ:LFMD) concerning possible violations of federal securities laws. LifeMD announced its second quarter 2025 results on August 5, 2025. Among other items, the Company revealed that higher customer

Freedom Holding Corp. (NASDAQ: FRHC), a global financial services and technology company, announced that the world's largest investment company, BlackRock, Inc., has increased its stake in the company to 0.85%, investing about $89 million. BlackRock has become the company's second-largest shareholder by shares, following its founder and CEO, entrepreneur Timur Turlov. https://mma.prnewswire.com/media/2761536/Freedom_Holding_Corp.jpg According to Bloomberg,

Johnson & Johnson (NYSE: JNJ)- Late breaking clinical science data, presented at the European Society of Cardiology (ESC) Congress today and simultaneously published in the New England Journal of Medicine (NEJM), finds at up to 10 years, when compared to standard care, routine use of Impella CP® in patients who have had a heart attack

(NASDAQ:CYTK), Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardiology New Analysis Shows Annual Incidence Rate of Atrial Fibrillation with Aficamten is 1.5%, Consistent with Expected Rates in Prediction Model of Patients with HCM; Simultaneous Publication in Heart Rhythm

Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025 GlobeNewswire August 31, 2025 Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardiology New Analysis Shows Annual Incidence Rate of Atrial Fibrillation with Aficamten

NEW YORK, NY / ACCESS Newswire / August 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeMD, Inc. ("LifeMD, Inc.") (NASDAQ:LFMD) concerning possible violations of federal securities laws. LifeMD announced its second quarter 2025 results on August 5, 2025. Among other items, the Company revealed that higher customer

NEW YORK, NY / ACCESS Newswire / August 31, 2025 / If you suffered a loss on your Sable Offshore Corp. (NYSE:SOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sable-offshore-corp-lawsuit-submission-form?prid=164570&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

(NYSE MKT:ELLO),(TASE:ELLO.TA), TEL-AVIV, Israel, Aug. 31, 2025 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and USA, today reported the publication in Israel of financial statements as of and for the three